Moreover, although there are differences in the prevalence of some genetic alterations and gene expression patterns, there are no differential molecular markers in the mutational landscape between EBV+ and EBV− lymphomas, including mutations in the MYC gene [42,162,192,250,263];. Here, MYC is linked to lymphoma.